Park Ha Biological Technology is trading 5.81% down now at $2.27 after renewed investor alerts highlighted securities-fraud allegations and the September 28, 2026 lead-plaintiff deadline.
- Multiple law firms continue publicizing the class action.
- It covers investors who acquired securities between December 27, 2024 and July 8, 2025.
- The decline is occurring despite broad gains in major U.S. indexes, pointing to company-specific legal pressure.